Nicolas Aide

Research interests

Publications

• Joint EANM/SNMMI/ANZSNM practice guidelines/procedure standards on recommended use of [18F]FDG PET/CT imaging during immunomodulatory treatments in patients with solid tumors version 1.0

  European Journal of Nuclear Medicine and Molecular Imaging · 2022 · 10.1007/s00259-022-05780-2

• Emerging and Evolving Concepts in Cancer Immunotherapy Imaging

  Radiology · 2022 · 10.1148/radiol.210518

• New PET technologies – embracing progress and pushing the limits

  European Journal of Nuclear Medicine and Molecular Imaging · 2021 · 10.1007/s00259-021-05390-4

• EANM guideline on the role of 2-[18F]FDG PET/CT in diagnosis, staging, prognostic value, therapy assessment and restaging of ovarian cancer, endorsed by the American College of Nuclear Medicine (ACNM), the Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the International Atomic Energy Agency (IAEA)

  European Journal of Nuclear Medicine and Molecular Imaging · 2021 · 10.1007/s00259-021-05450-9

• Baseline 18F-FDG PET radiomic features as predictors of 2-year event-free survival in diffuse large B cell lymphomas treated with immunochemotherapy

  European Radiology · 2020 · 10.1007/s00330-020-06815-8

• Evaluation of a new multipurpose whole-body CzT-based camera: comparison with a dual-head Anger camera and first clinical images

  EJNMMI Physics · 2020 · 10.1186/s40658-020-0284-5

• FDG PET/CT for assessing tumour response to immunotherapy

  European Journal of Nuclear Medicine and Molecular Imaging · 2018 · 10.1007/s00259-018-4171-4

• EANM/EARL harmonization strategies in PET quantification: from daily practice to multicentre oncological studies

  European Journal of Nuclear Medicine and Molecular Imaging · 2017 · https://doi.org/10.1007/s00259-017-3740-2

• F18-choline PET/CT guided surgery in primary hyperparathyroidism when ultrasound and MIBI SPECT/CT are negative or inconclusive: the APACH1 study

  European Journal of Nuclear Medicine and Molecular Imaging · 2017 · 10.1007/s00259-017-3911-1

• Phase II Study of a Radiotherapy Total Dose Increase in Hypoxic Lesions Identified by 18F-Misonidazole PET/CT in Patients with Non–Small Cell Lung Carcinoma (RTEP5 Study)

  Journal of Nuclear Medicine · 2017 · 10.2967/jnumed.116.188367

• Giant-cell arteritis: concordance study between aortic CT angiography and FDG-PET/CT in detection of large-vessel involvement

  European Journal of Nuclear Medicine and Molecular Imaging · 2017 · 10.1007/s00259-017-3774-5

• Repetitive 18F-FDG-PET/CT in patients with large-vessel giant-cell arteritis and controlled disease

  European Journal of Internal Medicine · 2017 · 10.1016/j.ejim.2017.08.013

• 18F-FDG PET/CT heterogeneity quantification through textural features in the era of harmonisation programs: a focus on lung cancer

  European Journal of Nuclear Medicine and Molecular Imaging · 2016 · 10.1007/s00259-016-3441-2

• Harmonizing FDG PET quantification while maintaining optimal lesion detection: prospective multicentre validation in 517 oncology patients

  European Journal of Nuclear Medicine and Molecular Imaging · 2015 · 10.1007/s00259-015-3128-0

• Staging the axilla in breast cancer patients with 18F-FDG PET: how small are the metastases that we can detect with new generation clinical PET systems?

  European Journal of Nuclear Medicine and Molecular Imaging · 2014 · 10.1007/s00259-014-2689-7

• Harmonizing SUVs in multicentre trials when using different generation PET systems: prospective validation in non-small cell lung cancer patients

  European Journal of Nuclear Medicine and Molecular Imaging · 2013 · 10.1007/s00259-013-2391-1

• F18-Choline, a Novel PET Tracer for Parathyroid Adenoma?

  The Journal of Clinical Endocrinology & Metabolism · 2013 · 10.1210/jc.2013-2084

• Dual-Phase 99mTc Sestamibi Scintigraphy With Neck and Thorax SPECT/CT in Primary Hyperparathyroidism

  Clinical Nuclear Medicine · 2012 · 10.1097/rlu.0b013e31823362e5

• Impact of Point Spread Function Reconstruction on Thoracic Lymph Node Staging With 18F-FDG PET/CT in Non–Small Cell Lung Cancer

  Clinical Nuclear Medicine · 2012 · 10.1097/rlu.0b013e318251e3d1

• Postablation 131I scintigraphy with neck and thorax SPECT–CT and stimulated serum thyroglobulin level predict the outcome of patients with differentiated thyroid cancer

  European Journal of Endocrinology · 2011 · 10.1530/eje-11-0156

• High-Contrast PET of Melanoma Using 18F-MEL050, a Selective Probe for Melanin with Predominantly Renal Clearance

  Journal of Nuclear Medicine · 2010 · 10.2967/jnumed.109.070060

• Clinical Relevance of Single-Photon Emission Computed Tomography/Computed Tomography of the Neck and Thorax in Postablation 131I Scintigraphy for Thyroid Cancer

  The Journal of Clinical Endocrinology & Metabolism · 2009 · 10.1210/jc.2008-2313

• Can fluorodihydroxyphenylalanine PET replace somatostatin receptor scintigraphy in patients with digestive endocrine tumors?

  PubMed · 2006

• Efficiency of [ 18 F]FDG PET in characterising renal cancer and detecting distant metastases: a comparison with CT

  European Journal of Nuclear Medicine and Molecular Imaging · 2003 · 10.1007/s00259-003-1211-4

Current projects

No projects listed.